Stony Brook, NY, United States of America

Vu Nguyen


Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Vu Nguyen in Tumor-Infiltrating Lymphocyte Quantification

Introduction

Vu Nguyen is an accomplished inventor based in Stony Brook, NY (US). He has made significant contributions to the field of clinical pathology through his innovative patent. His work focuses on the quantification of tumor-infiltrating lymphocytes (TILs), which are crucial for understanding tumor behavior and patient prognosis.

Latest Patents

Vu Nguyen holds a patent titled "System and method to quantify tumor-infiltrating lymphocytes (TILs) for clinical pathology analysis based on prediction, spatial analysis, molecular correlation, and reconstruction of TIL information identified in digitized tissue images." This patent describes a sophisticated system that quantifies the density of TILs using digitized diagnostic and stained whole-slide image data. The system employs convolutional autoencoding to segment image data and classify regions of interest based on lymphocyte density. It also includes a method for adjusting classification thresholds to improve accuracy in identifying lymphocyte infiltration.

Career Highlights

Throughout his career, Vu Nguyen has worked with prestigious institutions, including the State University of New York and the University of Texas System. His experience in these organizations has allowed him to develop and refine his innovative approaches to pathology analysis.

Collaborations

Vu Nguyen has collaborated with notable professionals in his field, including Joel Haskin Saltz and Tahsin M Kurc. These collaborations have contributed to the advancement of research in tumor-infiltrating lymphocytes and their implications in clinical settings.

Conclusion

Vu Nguyen's innovative work in quantifying tumor-infiltrating lymphocytes represents a significant advancement in clinical pathology. His contributions are poised to enhance the understanding of tumor behavior and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…